Oncology Institute, Inc.

TOI Nasdaq CIK: 0001799191

Company Information

Industry Services-Offices & Clinics of Doctors of Medicine
SIC Code 8011
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 18000 STUDEBAKER RD, CERRITOS, CA, 90703
Mailing Address 18000 STUDEBAKER RD, CERRITOS, CA, 90703
Phone 562-735-3226
Fiscal Year End 1231
EIN 843562323

Financial Overview

FY2024

-$83.07M
Net Income
$123.17M
Stockholders' Equity

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G Passive beneficial ownership (>5%) January 15, 2026 View on SEC
8-K Current report of material events January 12, 2026 View on SEC
3 Initial insider ownership report January 12, 2026 View on SEC
8-K Current report of material events January 7, 2026 View on SEC
4/A Insider transaction amendment January 6, 2026 View on SEC
4 Insider stock transaction report January 5, 2026 View on SEC
4 Insider stock transaction report December 16, 2025 View on SEC
8-K Current report of material events December 1, 2025 View on SEC
4 Insider stock transaction report December 1, 2025 View on SEC
4 Insider stock transaction report November 24, 2025 View on SEC

Insider Trading

SELL 3 insiders 5 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 8011)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.